Cargando…

The dual role of empagliflozin: Cardio renal protection in T2DM patients

Empagliflozin (Jardiance®) is an insulin independent antihyperglycemic agent used in treatment of T2D.The drug is a sodium glucose cotransporter-2 (SGLT2) inhibitor approved in USA and Europe and other countries of the world. As empagliflozin demonstrates cardioprotective and Reno protective propert...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shafiq, Aimen, Mahboob, Eman, Samad, Muhammad Ammar, Ur Rehman, Mohammad Hassam, Tharwani, Zoaib Habib
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486862/ https://www.ncbi.nlm.nih.gov/pubmed/36147179 http://dx.doi.org/10.1016/j.amsu.2022.104555

Ejemplares similares

Types of T-cell lymphoma-a cytogenetic perspective
por: Samad, Muhammad Ammar, et al.
Publicado: (2022)

Maternal mortality and its prominence in the Syrian Arab Republic: Challenges, efforts, and recommendations
por: Butt, Malaika Saeed, et al.
Publicado: (2022)

The urgency of suicide prevention in Afghanistan: challenges and recommendations
por: Tharwani, Zoaib Habib, et al.
Publicado: (2022)

Empagliflozin and Cardio-renal Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease – Implications for Clinical Practice
por: Fitchett, David H
Publicado: (2018)

Maternal mortality in Pakistan: Challenges, efforts, and recommendations
por: Shaeen, Sean Kaisser, et al.
Publicado: (2022)

Impact of facemasks on the mouth as an emerging dental concern: A survey among residents of Karachi
por: Muzzamil, Muhammad, et al.
Publicado: (2023)

Intramuscular myxoma of the thigh: A case report
por: Jabbar, Samra, et al.
Publicado: (2023)

Typhoid in Pakistan: Challenges, Efforts, and Recommendations
por: Tharwani, Zoaib Habib, et al.
Publicado: (2022)

Mental health impacts of earthquake on Afghans amidst humanitarian crisis
por: Hussaini, Sayed Jawad, et al.
Publicado: (2022)

Empagliflozin protects against renal ischemia/reperfusion injury in mice
por: Wang, Qifeng, et al.
Publicado: (2022)

Intergenerational trauma: A silent contributor to mental health deterioration in Afghanistan
por: Ullah, Hamid, et al.
Publicado: (2023)

Chronic myeloid leukemia: a type of MPN
por: Samad, Muhammad Ammar, et al.
Publicado: (2022)

Double trouble: COVID-19 vaccine misinformation amidst conflict in Ukraine
por: Zoaib Habib, Tharwani, et al.
Publicado: (2022)

Cardio-protective and anti-cancer therapeutic potential of Nigella sativa
por: Shafiq, Hammad, et al.
Publicado: (2014)

Polio amid a humanitarian crisis in Afghanistan: challenges and recommendations
por: Tharwani, Zoaib Habib, et al.
Publicado: (2022)

Impact of diabetes duration on left ventricular mass regression with empagliflozin
por: Moroney, Michael, et al.
Publicado: (2023)

What has been learned about COVID‐19 vaccine hesitancy in Pakistan: Insights from a narrative review
por: Tharwani, Zoaib Habib, et al.
Publicado: (2022)

Empagliflozin inhibits Na(+)/H(+) exchanger activity in human atrial cardiomyocytes
por: Trum, Maximilian, et al.
Publicado: (2020)

How to Demonstrate the Impact of Cardiac Rehabilitation on Cardio-renal Protection
por: Imamura, Teruhiko
Publicado: (2019)

Cardio-renal syndrome
por: Gnanaraj, Joseph, et al.
Publicado: (2016)

Toward a meta-vaccine future: Promoting vaccine confidence in the metaverse
por: Nawaz, Faisal A, et al.
Publicado: (2023)

Molecular Mechanisms Linking Empagliflozin to Renal Protection in the LLC-PK1 Model of Diabetic Nephropathy
por: Mihaljević, Vjera, et al.
Publicado: (2022)

Empagliflozin reduces Ca/calmodulin‐dependent kinase II activity in isolated ventricular cardiomyocytes
por: Mustroph, Julian, et al.
Publicado: (2018)

Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure
por: Thiele, Kirsten, et al.
Publicado: (2022)

Baseline neutrophil‐to‐lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodelling
por: Verma, Raj, et al.
Publicado: (2023)

Monkeypox Virus and Other Emerging Outbreaks: An Overview and Future Perspective
por: Hamdana, Amatul Hadi, et al.
Publicado: (2023)

The cardio-protective diet
por: Sivasankaran, S.
Publicado: (2010)

Empagliflozin and Renal Sodium-Hydrogen Exchange in Healthy Subjects
por: Biancalana, Edoardo, et al.
Publicado: (2023)

Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA‐REG OUTCOME
por: Pellicori, Pierpaolo, et al.
Publicado: (2020)

Infant & Child Mortality in Pakistan and its Determinants: A Review
por: Tharwani, Zoaib Habib, et al.
Publicado: (2023)

Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology
por: Abdelgawad, Ibrahim Y., et al.
Publicado: (2019)

Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study
por: Pagnesi, Matteo, et al.
Publicado: (2021)

The impact of COVID-19 on cardio-oncology care in Taiwan
por: Kang, Nai-Wen, et al.
Publicado: (2022)

Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)/H(+) exchanger in rats and rabbits
por: Baartscheer, Antonius, et al.
Publicado: (2016)

Time to cardiovascular benefits of empagliflozin: a post hoc observation from the EMPA‐REG OUTCOME trial
por: Verma, Subodh, et al.
Publicado: (2021)

MON-645 Association of Baseline Cardio-Metabolic Parameters on the Treatment Effects of Empagliflozin When Added to Metformin in Patients with T2D
por: Inzucchi, Silvio E, et al.
Publicado: (2020)

Burnout in health care workers during the fourth wave of COVID-19: A cross sectional study from Pakistan
por: Ahmad, Shoaib, et al.
Publicado: (2022)

Peripartum Cardiomyopathy During Puerperium Co-existing with Pre-eclampsia and Complicated by Acute Renal Failure: A Case Report
por: Akbar, Arshia, et al.
Publicado: (2019)

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009)

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bc4b00m0vk4bh9quhpbmq5iln5